Global Nuclear Medicine-Radiopharmaceuticals Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Global Nuclear Medicine-Radiopharmaceuticals Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Analysis of the Nuclear Medicine Radiopharmaceuticals Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Nuclear Medicines are primarily drugs that contain radioactive elements for radionuclide-emitting ionizing radiations. Their core application lies in the diagnosis and treatment of various diseases that conventional medicines fail to achieve. Radiopharmaceuticals are unique as they are used to directly target specific organs sites in the body where the drug can emit radiations. These radiations are then captured by gamma cameras placed in proximity of the patient. The radiation dose in these pharmaceuticals is kept as low as possible to avoid the side effects of radiation exposure.
Based on the Nuclear Medicine-Radiopharmaceuticals market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Nuclear Medicine-Radiopharmaceuticals market covered in Chapter 5:
Alliance Medical (UK)
Triad Isotopes, Inc. (US)
Bracco Imaging S.p.A (Italy)
Siemens Healthcare (US)
Positron Corporation (US)
GE Healthcare (UK)
Lantheus Medical Imaging Inc (US)
Ion Beam Applications S.A (Belgium)
Medi-Radiopharma Ltd (Hungary)
Jubilant Pharma (India)
Actinium Pharmaceuticals Inc (US)
Advanced Medical Isotope Corporation (US)
Cardinal Health, Inc (US)
Nordion, Inc. (Canada)
Bayer HealthCare Medical Care (US)
Peregrine Pharmaceuticals, Inc. (US)
Alseres Pharmaceuticals, Inc (US)
Immunomedics, Inc. (US)
Avid Radiopharmaceuticals (US)
Mallinckrodt Pharmaceuticals (Ireland)
In Chapter 6, on the basis of types, the Nuclear Medicine-Radiopharmaceuticals market from 2015 to 2025 is primarily split into:
Diagnostic Medicine
Therapeutic Medicine
In Chapter 7, on the basis of applications, the Nuclear Medicine-Radiopharmaceuticals market from 2015 to 2025 covers:
SPECT
PET
Therapeutic
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Nuclear Medicine-Radiopharmaceuticals Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Alliance Medical (UK)
5.1.1 Alliance Medical (UK) Company Profile
5.1.2 Alliance Medical (UK) Business Overview
5.1.3 Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.2 Triad Isotopes, Inc. (US)
5.2.1 Triad Isotopes, Inc. (US) Company Profile
5.2.2 Triad Isotopes, Inc. (US) Business Overview
5.2.3 Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.3 Bracco Imaging S.p.A (Italy)
5.3.1 Bracco Imaging S.p.A (Italy) Company Profile
5.3.2 Bracco Imaging S.p.A (Italy) Business Overview
5.3.3 Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.4 Siemens Healthcare (US)
5.4.1 Siemens Healthcare (US) Company Profile
5.4.2 Siemens Healthcare (US) Business Overview
5.4.3 Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.5 Positron Corporation (US)
5.5.1 Positron Corporation (US) Company Profile
5.5.2 Positron Corporation (US) Business Overview
5.5.3 Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.6 GE Healthcare (UK)
5.6.1 GE Healthcare (UK) Company Profile
5.6.2 GE Healthcare (UK) Business Overview
5.6.3 GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.7 Lantheus Medical Imaging Inc (US)
5.7.1 Lantheus Medical Imaging Inc (US) Company Profile
5.7.2 Lantheus Medical Imaging Inc (US) Business Overview
5.7.3 Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.8 Ion Beam Applications S.A (Belgium)
5.8.1 Ion Beam Applications S.A (Belgium) Company Profile
5.8.2 Ion Beam Applications S.A (Belgium) Business Overview
5.8.3 Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.9 Medi-Radiopharma Ltd (Hungary)
5.9.1 Medi-Radiopharma Ltd (Hungary) Company Profile
5.9.2 Medi-Radiopharma Ltd (Hungary) Business Overview
5.9.3 Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.10 Jubilant Pharma (India)
5.10.1 Jubilant Pharma (India) Company Profile
5.10.2 Jubilant Pharma (India) Business Overview
5.10.3 Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.11 Actinium Pharmaceuticals Inc (US)
5.11.1 Actinium Pharmaceuticals Inc (US) Company Profile
5.11.2 Actinium Pharmaceuticals Inc (US) Business Overview
5.11.3 Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.12 Advanced Medical Isotope Corporation (US)
5.12.1 Advanced Medical Isotope Corporation (US) Company Profile
5.12.2 Advanced Medical Isotope Corporation (US) Business Overview
5.12.3 Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.13 Cardinal Health, Inc (US)
5.13.1 Cardinal Health, Inc (US) Company Profile
5.13.2 Cardinal Health, Inc (US) Business Overview
5.13.3 Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.14 Nordion, Inc. (Canada)
5.14.1 Nordion, Inc. (Canada) Company Profile
5.14.2 Nordion, Inc. (Canada) Business Overview
5.14.3 Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.15 Bayer HealthCare Medical Care (US)
5.15.1 Bayer HealthCare Medical Care (US) Company Profile
5.15.2 Bayer HealthCare Medical Care (US) Business Overview
5.15.3 Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.16 Peregrine Pharmaceuticals, Inc. (US)
5.16.1 Peregrine Pharmaceuticals, Inc. (US) Company Profile
5.16.2 Peregrine Pharmaceuticals, Inc. (US) Business Overview
5.16.3 Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.17 Alseres Pharmaceuticals, Inc (US)
5.17.1 Alseres Pharmaceuticals, Inc (US) Company Profile
5.17.2 Alseres Pharmaceuticals, Inc (US) Business Overview
5.17.3 Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.18 Immunomedics, Inc. (US)
5.18.1 Immunomedics, Inc. (US) Company Profile
5.18.2 Immunomedics, Inc. (US) Business Overview
5.18.3 Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.18.4 Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.19 Avid Radiopharmaceuticals (US)
5.19.1 Avid Radiopharmaceuticals (US) Company Profile
5.19.2 Avid Radiopharmaceuticals (US) Business Overview
5.19.3 Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.19.4 Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Products Introduction
5.20 Mallinckrodt Pharmaceuticals (Ireland)
5.20.1 Mallinckrodt Pharmaceuticals (Ireland) Company Profile
5.20.2 Mallinckrodt Pharmaceuticals (Ireland) Business Overview
5.20.3 Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.20.4 Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Types (2015-2020)
6.1.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Types (2015-2020)
6.1.3 Global Nuclear Medicine-Radiopharmaceuticals Price by Types (2015-2020)
6.2 Global Nuclear Medicine-Radiopharmaceuticals Market Forecast by Types (2020-2025)
6.2.1 Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Nuclear Medicine-Radiopharmaceuticals Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Nuclear Medicine-Radiopharmaceuticals Sales, Price and Growth Rate of Diagnostic Medicine
6.3.2 Global Nuclear Medicine-Radiopharmaceuticals Sales, Price and Growth Rate of Therapeutic Medicine
6.4 Global Nuclear Medicine-Radiopharmaceuticals Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Diagnostic Medicine Market Revenue and Sales Forecast (2020-2025)
6.4.2 Therapeutic Medicine Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Applications (2015-2020)
7.1.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Applications (2015-2020)
7.2 Global Nuclear Medicine-Radiopharmaceuticals Market Forecast by Applications (2020-2025)
7.2.1 Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Nuclear Medicine-Radiopharmaceuticals Revenue, Sales and Growth Rate of SPECT (2015-2020)
7.3.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue, Sales and Growth Rate of PET (2015-2020)
7.3.3 Global Nuclear Medicine-Radiopharmaceuticals Revenue, Sales and Growth Rate of Therapeutic (2015-2020)
7.4 Global Nuclear Medicine-Radiopharmaceuticals Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 SPECT Market Revenue and Sales Forecast (2020-2025)
7.4.2 PET Market Revenue and Sales Forecast (2020-2025)
7.4.3 Therapeutic Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Nuclear Medicine-Radiopharmaceuticals Sales by Regions (2015-2020)
8.2 Global Nuclear Medicine-Radiopharmaceuticals Market Revenue by Regions (2015-2020)
8.3 Global Nuclear Medicine-Radiopharmaceuticals Market Forecast by Regions (2020-2025)
9 North America Nuclear Medicine-Radiopharmaceuticals Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
9.3 North America Nuclear Medicine-Radiopharmaceuticals Market Revenue and Growth Rate (2015-2020)
9.4 North America Nuclear Medicine-Radiopharmaceuticals Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Nuclear Medicine-Radiopharmaceuticals Market Analysis by Country
9.6.1 U.S. Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
9.6.2 Canada Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
9.6.3 Mexico Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
10 Europe Nuclear Medicine-Radiopharmaceuticals Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
10.3 Europe Nuclear Medicine-Radiopharmaceuticals Market Revenue and Growth Rate (2015-2020)
10.4 Europe Nuclear Medicine-Radiopharmaceuticals Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Nuclear Medicine-Radiopharmaceuticals Market Analysis by Country
10.6.1 Germany Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
10.6.2 United Kingdom Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
10.6.3 France Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
10.6.4 Italy Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
10.6.5 Spain Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
10.6.6 Russia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
11 Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Market Analysis by Country
11.6.1 China Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
11.6.2 Japan Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
11.6.3 South Korea Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
11.6.4 Australia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
11.6.5 India Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
12 South America Nuclear Medicine-Radiopharmaceuticals Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
12.3 South America Nuclear Medicine-Radiopharmaceuticals Market Revenue and Growth Rate (2015-2020)
12.4 South America Nuclear Medicine-Radiopharmaceuticals Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Nuclear Medicine-Radiopharmaceuticals Market Analysis by Country
12.6.1 Brazil Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
12.6.2 Argentina Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
12.6.3 Columbia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
13 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Analysis by Country
13.6.1 UAE Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
13.6.2 Egypt Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
13.6.3 South Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate 2015-2025
Table Nuclear Medicine-Radiopharmaceuticals Key Market Segments
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Revenue ($) Segment by Type from 2015-2020
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Nuclear Medicine-Radiopharmaceuticals
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Alliance Medical (UK) Company Profile
Table Alliance Medical (UK) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Alliance Medical (UK) Production and Growth Rate
Figure Alliance Medical (UK) Market Revenue ($) Market Share 2015-2020
Table Triad Isotopes, Inc. (US) Company Profile
Table Triad Isotopes, Inc. (US) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Triad Isotopes, Inc. (US) Production and Growth Rate
Figure Triad Isotopes, Inc. (US) Market Revenue ($) Market Share 2015-2020
Table Bracco Imaging S.p.A (Italy) Company Profile
Table Bracco Imaging S.p.A (Italy) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bracco Imaging S.p.A (Italy) Production and Growth Rate
Figure Bracco Imaging S.p.A (Italy) Market Revenue ($) Market Share 2015-2020
Table Siemens Healthcare (US) Company Profile
Table Siemens Healthcare (US) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Siemens Healthcare (US) Production and Growth Rate
Figure Siemens Healthcare (US) Market Revenue ($) Market Share 2015-2020
Table Positron Corporation (US) Company Profile
Table Positron Corporation (US) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Positron Corporation (US) Production and Growth Rate
Figure Positron Corporation (US) Market Revenue ($) Market Share 2015-2020
Table GE Healthcare (UK) Company Profile
Table GE Healthcare (UK) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GE Healthcare (UK) Production and Growth Rate
Figure GE Healthcare (UK) Market Revenue ($) Market Share 2015-2020
Table Lantheus Medical Imaging Inc (US) Company Profile
Table Lantheus Medical Imaging Inc (US) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Lantheus Medical Imaging Inc (US) Production and Growth Rate
Figure Lantheus Medical Imaging Inc (US) Market Revenue ($) Market Share 2015-2020
Table Ion Beam Applications S.A (Belgium) Company Profile
Table Ion Beam Applications S.A (Belgium) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Ion Beam Applications S.A (Belgium) Production and Growth Rate
Figure Ion Beam Applications S.A (Belgium) Market Revenue ($) Market Share 2015-2020
Table Medi-Radiopharma Ltd (Hungary) Company Profile
Table Medi-Radiopharma Ltd (Hungary) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Medi-Radiopharma Ltd (Hungary) Production and Growth Rate
Figure Medi-Radiopharma Ltd (Hungary) Market Revenue ($) Market Share 2015-2020
Table Jubilant Pharma (India) Company Profile
Table Jubilant Pharma (India) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Jubilant Pharma (India) Production and Growth Rate
Figure Jubilant Pharma (India) Market Revenue ($) Market Share 2015-2020
Table Actinium Pharmaceuticals Inc (US) Company Profile
Table Actinium Pharmaceuticals Inc (US) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Actinium Pharmaceuticals Inc (US) Production and Growth Rate
Figure Actinium Pharmaceuticals Inc (US) Market Revenue ($) Market Share 2015-2020
Table Advanced Medical Isotope Corporation (US) Company Profile
Table Advanced Medical Isotope Corporation (US) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Advanced Medical Isotope Corporation (US) Production and Growth Rate
Figure Advanced Medical Isotope Corporation (US) Market Revenue ($) Market Share 2015-2020
Table Cardinal Health, Inc (US) Company Profile
Table Cardinal Health, Inc (US) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Cardinal Health, Inc (US) Production and Growth Rate
Figure Cardinal Health, Inc (US) Market Revenue ($) Market Share 2015-2020
Table Nordion, Inc. (Canada) Company Profile
Table Nordion, Inc. (Canada) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Nordion, Inc. (Canada) Production and Growth Rate
Figure Nordion, Inc. (Canada) Market Revenue ($) Market Share 2015-2020
Table Bayer HealthCare Medical Care (US) Company Profile
Table Bayer HealthCare Medical Care (US) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bayer HealthCare Medical Care (US) Production and Growth Rate
Figure Bayer HealthCare Medical Care (US) Market Revenue ($) Market Share 2015-2020
Table Peregrine Pharmaceuticals, Inc. (US) Company Profile
Table Peregrine Pharmaceuticals, Inc. (US) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Peregrine Pharmaceuticals, Inc. (US) Production and Growth Rate
Figure Peregrine Pharmaceuticals, Inc. (US) Market Revenue ($) Market Share 2015-2020
Table Alseres Pharmaceuticals, Inc (US) Company Profile
Table Alseres Pharmaceuticals, Inc (US) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Alseres Pharmaceuticals, Inc (US) Production and Growth Rate
Figure Alseres Pharmaceuticals, Inc (US) Market Revenue ($) Market Share 2015-2020
Table Immunomedics, Inc. (US) Company Profile
Table Immunomedics, Inc. (US) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Immunomedics, Inc. (US) Production and Growth Rate
Figure Immunomedics, Inc. (US) Market Revenue ($) Market Share 2015-2020
Table Avid Radiopharmaceuticals (US) Company Profile
Table Avid Radiopharmaceuticals (US) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Avid Radiopharmaceuticals (US) Production and Growth Rate
Figure Avid Radiopharmaceuticals (US) Market Revenue ($) Market Share 2015-2020
Table Mallinckrodt Pharmaceuticals (Ireland) Company Profile
Table Mallinckrodt Pharmaceuticals (Ireland) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Mallinckrodt Pharmaceuticals (Ireland) Production and Growth Rate
Figure Mallinckrodt Pharmaceuticals (Ireland) Market Revenue ($) Market Share 2015-2020
Table Global Nuclear Medicine-Radiopharmaceuticals Sales by Types (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Share by Types (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue ($) by Types (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Share by Types (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Price ($) by Types (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Sales by Types (2020-2025)
Table Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Sales Share by Types (2020-2025)
Table Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Revenue ($) by Types (2020-2025)
Table Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Revenue Share by Types (2020-2025)
Figure Global Diagnostic Medicine Sales and Growth Rate (2015-2020)
Figure Global Diagnostic Medicine Price (2015-2020)
Figure Global Therapeutic Medicine Sales and Growth Rate (2015-2020)
Figure Global Therapeutic Medicine Price (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Revenue ($) and Growth Rate Forecast of Diagnostic Medicine (2020-2025)
Figure Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast of Diagnostic Medicine (2020-2025)
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Revenue ($) and Growth Rate Forecast of Therapeutic Medicine (2020-2025)
Figure Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast of Therapeutic Medicine (2020-2025)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales by Applications (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Share by Applications (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue ($) by Applications (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Share by Applications (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Sales by Applications (2020-2025)
Table Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Sales Share by Applications (2020-2025)
Table Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Revenue Share by Applications (2020-2025)
Figure Global SPECT Sales and Growth Rate (2015-2020)
Figure Global SPECT Price (2015-2020)
Figure Global PET Sales and Growth Rate (2015-2020)
Figure Global PET Price (2015-2020)
Figure Global Therapeutic Sales and Growth Rate (2015-2020)
Figure Global Therapeutic Price (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Revenue ($) and Growth Rate Forecast of SPECT (2020-2025)
Figure Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast of SPECT (2020-2025)
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Revenue ($) and Growth Rate Forecast of PET (2020-2025)
Figure Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast of PET (2020-2025)
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Revenue ($) and Growth Rate Forecast of Therapeutic (2020-2025)
Figure Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Forecast of Therapeutic (2020-2025)
Figure Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales by Regions (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Regions in 2019
Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue by Regions (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions in 2019
Table Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Sales by Regions (2020-2025)
Table Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Sales Share by Regions (2020-2025)
Table Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Nuclear Medicine-Radiopharmaceuticals Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure North America Nuclear Medicine-Radiopharmaceuticals Market Revenue and Growth Rate (2015-2020)
Figure North America Nuclear Medicine-Radiopharmaceuticals Market Forecast Sales (2020-2025)
Figure North America Nuclear Medicine-Radiopharmaceuticals Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Canada Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Mexico Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Market Revenue and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Market Forecast Sales (2020-2025)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure France Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Italy Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Spain Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Russia Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Market Forecast Sales (2020-2025)
Figure Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure South Korea Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Australia Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure India Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure South America Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure South America Nuclear Medicine-Radiopharmaceuticals Market Revenue and Growth Rate (2015-2020)
Figure South America Nuclear Medicine-Radiopharmaceuticals Market Forecast Sales (2020-2025)
Figure South America Nuclear Medicine-Radiopharmaceuticals Market Forecast Revenue ($) (2020-2025)
Figure Brazil Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Argentina Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Columbia Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Forecast Sales (2020-2025)
Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Forecast Revenue ($) (2020-2025)
Figure UAE Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure Egypt Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Figure South Africa Nuclear Medicine-Radiopharmaceuticals Market Sales and Growth Rate (2015-2020)
Research Methodology:
Nuclear Medicine Radiopharmaceuticals Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|